RBC Capital reiterates Verisk Analytics stock rating at Outperform

RBC Capital has reaffirmed its Outperform rating for Verisk Analytics (NASDAQ: VRSK) and maintained a $230.00 price target following a Delaware Supreme Court decision concerning the company's $2.35 billion AccuLynx acquisition. The Supreme Court validated the August 7 Chancery Court ruling which deemed Verisk's termination of the acquisition invalid, ordering Verisk to pursue FTC approval and close the deal if approved, while also compensating AccuLynx with roughly $3.85 million in direct costs plus interest.

Verisk has agreed to comply with these court orders, though the transaction is still contingent on normal closing conditions and FTC review. This acquisition, significant for Verisk's $25.6 billion market cap and $4.6 billion in total debt, is anticipated to elevate leverage to the low-3x range, potentially limiting capacity for share repurchases in the short term.

This shift is contrary to Verisk's recent share-buyback strategy. The stock appears undervalued according to InvestingPro's Fair Value analysis. However, RBC Capital anticipates modest dilution to earnings from the deal, noting it could raise concerns about GenAI disintermediation risks in the Information Services sector. Verisk reported Q2 adjusted earnings and revenue surpassing analyst estimates, reaffirmed its full-year outlook highlighting growth trends for the second half of the year.

Additionally, BMO Capital increased its price target for Verisk to $248, with an Outperform rating, citing stronger-than-expected margins and accelerated revenue growth. Meanwhile, Verisk filed an appeal with the Delaware Supreme Court in a separate case involving Acculynx.com.